Phase-controllable synthesis, shape evolution and optical performances of CePO4 nanocrystals via a simple oil-bath route

Huanhuan Chena, Yonghong Ni*a and Xiang Mab
aCollege of Chemistry and Materials Science, Key Laboratory of Functional Molecular Solids of Education Ministry, Anhui Laboratory of Molecule-Based Materials, Anhui Key Laboratory of Functional Molecular Solids, Anhui Normal University, 1 Beijing East Road, Wuhu, 241000, PR China. E-mail: niyh@mail.ahnu.edu.cn; Fax: +86-553-3869303
bCentres of Modern Analyses, Nanjing University, Nanjing, 210093, PR China

Received 13th July 2014 , Accepted 4th August 2014

First published on 5th August 2014


Abstract

Rare-earth inorganic orthophosphates have been attracting considerable research interest because of their significant luminescent properties. In the present work, we employed a facile oil-bath route to successfully realize phase-controlled synthesis of CePO4 nanocrystals. The reactions were carried out at 110 °C for 30 min. The phases of the as-obtained products were determined by X-ray powder diffraction (XRD) analyses. Experiments showed that a mixed phase of hexagonal and monoclinic CePO4 was prepared at the EG/H2O volume ratio of 14/5, keeping the introduced EG/H2O total volume of 19 mL unchanged. Hexagonal CePO4 nanocrystals were obtained at the EG/H2O volume ratio below 14/5; while at a volume ratio above 14/5, monoclinic ones were produced. Interestingly, the morphology of the final product underwent a change from long nanorods, to short nanorods, to nanorod bundles, to shuttle-like nanocrystals, and finally to spheroid nanocrystals with the increase of the EG/H2O volume ratio. Furthermore, the optical performances of the final products with different forms were also investigated.


1. Introduction

Over the past two decades, the synthesis and luminescent properties of lanthanide orthophosphates (LnPO4) and lanthanide(III)-doped lanthanide orthophosphates (LnPO4:Ln3+) has always attracted extensive interest because of their potential applications in color displays,1 field-effect transistors,2 optoelectronics,3 medical and biological labels,4 solar cells,5 and light sources.6 For example, CePO4 and doped CePO4 can be used in luminescent lamps as highly efficient emitters of green light.7 Generally, CePO4 bears two forms in nature: hexagonal structure with a chemical formula of CePO4·xH2O (x = 0.3–0.5) (known as Rhabdophane) and monoclinic one (monazite structure).8 The former is low-temperature stable and has wide applications in the tribology due to its layered structure.9 The latter is high temperature stable and can be obtained through calcining hexagonal CePO4. Owing to the melting-point of ∼2000 °C, monoclinic CePO4 is one of the most stable orthophosphate materials. It can be applied under the high temperature as heat-resistant and ceramic materials.10 Also, monoclinic CePO4 has a promising application as a potential storage material for nuclear waste because it can form solid solutions with tetravalent actinides, such as U4+ and Th4+, and can exist for billions of years.11 Moreover, it is found that CePO4 presents a potential application in hydrogen fuel cells as proton conduction membrane.12 Importantly, widened applications can be found in doped CePO4 materials. For instance, CePO4:Tb3+ nanocrystals have been extensively used in determination of vitamin C,13 formaldehyde,14 immunoassay,15 and sensing.16

Generally, CePO4 can be prepared by the solid-phase reaction and the solution-phase route. The solid-phase reaction is often carried out under high temperature, so the final product is always monoclinic CePO4. Now, however, the solution-phase route attracts much interest since it can conveniently control the morphology of the final product, which is difficult for the solid-phase preparation. For example, the microemulsion technology17 and the direct precipitation method18 have been developed for syntheses of CePO4 nanowires. Among various solution-phase routes, however, the hydrothermal technology is always extensively used for preparation of pure CePO4 and/or doped CePO4 nanocrystals with various shapes and sizes.19–22 Different from the high-temperature solid-phase reaction, hexagonal CePO4 is often prepared by the solution-phase route due to the low reaction temperature. Thus, the post-treatment is necessary for the conversion of the hexagonal to the monoclinic form. In 2003, Yang and coworkers hydrothermally prepared hexagonal and monoclinic CePO4 nanocrystals at 100 °C and 200 °C for 8 h, respectively,22 which is a useful attempt for the phase-controlled synthesis of CePO4 under the mild condition. However, it still remains a huge challenge for realizing rapid synthesis of CePO4 with controllable phase and shape through the hydrothermal method.

In the current paper, we successfully realized phase-controllable synthesis of nanosized CePO4 particles in a simple system through a mild oil-bath route. Ce(NO3)3·6H2O and KH2PO4 were selected as the reactants, ethylene glycol (EG) and water as the mixed media. No surfactant or structure-directing reagent was employed. The reaction was carried out at 110 °C for 30 min. It was found that CePO4 nanocrystals gradually changed from hexagonal to monoclinic phase with the increase of the EG/H2O volume ratio from 19/0 to 0/19. Simultaneously, the morphology of the final product evolved from long nanorods, to short nanorods, to nanorod bundles, to shuttle-like nanocrystals, and finally to spheroid nanocrystals. Furthermore, the optical performances of the final products with different phases were also investigated.

2. Experimental section

All reagents and chemicals are analytically pure, bought from Sinopharm Chemical Company and used without further purification.

2.1 Synthesis of CePO4

In a typical experimental process, 1.0 mmol (0.4342 g) of Ce(NO3)3·6H2O and 1.0 mmol (0.1361 g) KH2PO4 were firstly dissolved into 1 mL concentrated HNO3 in a 50 mL three-necked flask. Then, 19 mL mixed solvents of ethylene glycol (EG) and H2O with the volume ratio of 0/19, 2/17, 4/15, 6/13, 8/11, 10/9, 12/7, 14/5, 16/3, 18/1 and 19/0 were added into the above solution, respectively. After the as-obtained systems were heated in oil bath at 110 °C for 30 min, the systems were cooled down to room temperature naturally. The white precipitates were collected and washed with deionized water several times, and finally dried at 60 °C for 12 h in vacuum oven.

2.2 Characterization

X-ray diffraction (XRD) patterns of the products were carried out on Shimadzu XRD-6000 X-ray diffractometer (Cu Kα radiation, k = 0.154060 nm), employing a scanning rate of 0.02 s−1 and 2θ ranges from 10° to 80°. Morphological and elemental analyses of the as-obtained products were accomplished on a Hitachi S-4800 field emission scanning electron microscope (SEM), employing an accelerating voltage of 5 kV and 15 kV (for energy dispersive spectrum analysis). High resolution transmission electron microscopy (HR/TEM) images were carried out on a JEOL 2010 transmission electron microscope, employing an accelerating voltage of 200 kV. The holey carbon film was used as the support. Photoluminescence (PL) spectra were recorded on a FLSP 920 with a Xe lamp at room temperature. The UV-vis diffuse reflectance spectra (DRS) were recorded by a Shimadzu UV2450 spectrometer using MgO as a standard at room temperature.

3. Results and discussion

3.1 Structure and morphology characterization

Fig. 1a depicts the XRD patterns of the products prepared by the present oil-bath route from the systems with various EG/H2O volume ratios at 110 °C for 30 min. With the increase of the EG/H2O volume ratio from 0/19 to 12/7, the products exhibited same XRD patterns, which were indexed as hexagonal CePO4 phase by comparison with JCPDS card files no.74-1889. After increasing the EG/H2O volume ratio to 14/5, the hexagonal and monoclinic phases were detected simultaneously, implying that the final product was a mixture composed of hexagonal and monoclinic CePO4. Upon further increasing the EG/H2O volume ratio, hexagonal CePO4 gradually decreased and monoclinic one increased. After the EG/H2O volume ratio were increased to 16/3, the final product could be arranged to monoclinic CePO4 by comparison with JCPDS card files no.73-0478. Fig. 1b gives the EDS analyses of the products prepared from systems with the EG/H2O volume ratio of 0/19 and 19/0, respectively. Two products presented the same EDS result although they owned different forms. The above experimental facts indicated that the phase-controlled synthesis of CePO4 could be realized only via changing the original EG/H2O volume ratio in the present simple system.
image file: c4ra07052f-f1.tif
Fig. 1 (a) XRD patterns of the products prepared from systems with various EG/H2O volume ratios by the present oil-bath route at 110 °C for 30 min, (b) the EDS analyses of the products prepared from systems with the EG/H2O volume ratios of 0/19 and 19/0, respectively.

SEM observations showed that the morphology of the final product could also be tuned by the original EG/H2O volume ratio. As shown in Fig. 2a, when the EG/H2O volume ratio was 0/19, the product comprised of plentiful long nanorods. After increasing the EG/H2O volume ratio to 6/13, the product was made of abundant short nanorods; and some short nanorods collocated with each other to form nanorod bundles (see Fig. 2b). Upon further enhancing the EG/H2O volume ratio to 12/7, nanorod bundles with integrated midsections started to appear (Fig. 2c). According to the XRD result shown in Fig. 1a, the final product still belonged to the hexagonal phase. After the EG/H2O volume ratio of 14/5 was used, the product presented dumbbell-like structures constructed by nanorod bundles with integrated midsections (Fig. 2d). Here, the product was a mixture of hexagonal and monoclinic form based on the XRD analysis. After increasing the volume ratio of EG/H2O to 16/3, only monoclinic CePO4 was obtained. Simultaneously, carrot-like products were formed due to the ceaseless growth of the midsections of nanorod bundles (see Fig. 2e). Upon further enhancing the volume ratio of EG/H2O to 18/1, the final product was composed of shuttle-like grains (Fig. 2f). After only 19 mL EG was employed, the product displayed spheroid-like structures (Fig. 2g). The above experimental facts clearly disclosed the shape transformation of CePO4 from long nanorods, to short nanorods, to dumbbell-like structures, to carrot-like structures, to shuttle-like grains, and finally to spheroid-like grains with the increase of the EG/H2O volume ratio from 0/19 to 19/0.


image file: c4ra07052f-f2.tif
Fig. 2 SEM images of the products obtained from systems with different ratios of EG/H2O: (a) 0/19, (b) 6/13, (c) 12/7, (d) 14/5, (e) 16/3, (f) 18/1 and (g) 19/0.

Fig. 3 depicts representative TEM images of the products prepared from systems with the EG/H2O volume ratio of 0/19, 12/7, 16/3 and 18/1, respectively. As seen from Fig. 3a, the final product prepared from the system with the EG/H2O volume ratio of 0/19 was made of long nanorods with smooth surfaces. A HRTEM images is exhibited in the inset of Fig. 3a. The clear lattice fringes showed good crystallinity of nanorods. The distance between neighbouring planes was measured to be ∼0.31 nm, which is very close to 0.30936 nm of the (111) plane and 0.30549 nm of the (200) one. Furthermore, a SAED pattern is displayed in the inset of Fig. 3a, too. Regular and bright diffraction dots confirmed the single crystal nature of nanorods. Combining HRTEM image, SAED pattern and XRD pattern, one can find that nanorods should grow along the [001] direction of hexagonal CePO4. This is consistent of the growth habit of hexagonal CePO4.21 However, several weak diffraction dots also existed in the SAED pattern, which were attributed to the monoclinic CePO4. For example, two spots could be indexed as the (012) plane in the SAED pattern. The upper spot belonged to hexagonal CePO4 and the below one to monoclinic CePO4. The above fact implied the final product was a mixture of hexagonal and monoclinic CePO4 although monoclinic CePO4 could not be detected by XRD analyses. Fig. 3b shows a typical TEM image of the product obtained from the system with the EG/H2O volume ratio of 12/7. The product was composed of short nanorods and nanorod bundles with integrated midsection. The inset in Fig. 3b displayed the HRTEM image and SAED pattern of a short nanorod. The lattice fringes and diffraction dots could still be detected, indicating that the product still owned good crystallinity. However, the product had shown marked polycrystalline feature compared with long nanorods given in Fig. 3a. Fig. 3c displays two carrot-like grains, which were obtained from the system with the EG/H2O volume ratio of 16/3. This was in consistent with the SEM result shown in Fig. 2e. The HRTEM image exhibited two intersecting planes, which corresponded the (−212) and (200) one of monoclinic CePO4 form, respectively (see the inset in Fig. 3c). Fig. 3d depicts a representative TEM image of the product prepared from the system with the EG/H2O volume ratio of 18/1. A shuttle-like particle was clearly visible. Also, a HRTEM image given in the inset in Fig. 3c exhibited clear stripes, indicating the product owned good crystallinity. Obviously, TEM observations likewise uncovered the shape conversion of the final product with the increase of the EG/H2O volume ratio, which were consistent with the SEM results.


image file: c4ra07052f-f3.tif
Fig. 3 TEM and HRTEM images of the final CePO4 products prepared from systems with different ratios of EG/H2O: (a) EG/H2O = 0/19, (b) EG/H2O = 12/7, (c) EG/H2O = 16/3 and (d) EG/H2O = 18/1.

3.2 Possible formation mechanism

Many studies have discovered that hexagonal CePO4 nanowires/nanorods can be easily obtained from hydrothermal systems.21,22 Fang et al. explained the above fact from the structural viewpoint of hexagonal CePO4.21 It was considered that hexagonal CePO4 comprised infinite linear chains extending along the c axis. Thus, from the thermodynamic perspective, the growth of hexagonal CePO4 along the c axis direction needed the lowest activation energy. This caused a higher growth rate along the c axis. Namely, CePO4 grew preferentially along the [001] direction and led to the abnormally strong intensity of the (200) peak in the XRD pattern of hexagonal CePO4.21 In the present work, the system consisted of Ce(NO3)3, KH2PO4, H2O and/or EG. No additive was employed. When only H2O (the EG/H2O volume ratio = 0/19) was used, hexagonal CePO4 long nanorods were obtained. The XRD pattern indeed showed the abnormally strong intensity of the (200) peak (see Fig. 1), implying the preferential growth along the [001] direction. Also, the above result was proved by the SAED pattern and HRTEM image (see the inset in Fig. 3a). With the increase of EG amount in the system, the phase and morphology of CePO4 gradually changed under the same oil-bath conditions. After only EG (the EG/H2O volume ratio = 19/0) was employed, spheroid-like monoclinic CePO4 particles were formed. Distinctly, EG played a crucial role in the phase- and morphology-controlled synthesis of CePO4. In 1998, Fasol's research uncovered that faster ionic motion usually ensured a reversible pathway between the fluid phase and solid phase and allowed ions to adopt correct positions in developing crystal lattices.23 It is well known that EG has a bigger viscosity than water. Therefore, the system viscosity increased with the increase of the EG/H2O volume ratio, which gradually slowed down the motion rate of Ce3+ and PO43− ions. This was unfavorable for the growth of hexagonal CePO4 nanorods. On the other hand, two –OH groups exist in an EG molecule. It is possible that a chelate ion is formed between EG and Ce3+ ion owing to the strong affinity of cerium to oxygen. Namely, EG could still act as a structure-directing reagent in the formation of CePO4 micro/nanostructures with certain phases and shapes. Thus, with the increase of the EG/H2O volume ratio from 0/19 to 19/0, the phase of CePO4 changed from hexagonal to monoclinic and the morphology evolved from long nanorods, to nanorod bundles, to dumbbell-like structures, to shuttle-like grains and finally to spheroid-like particles. Scheme 1 clearly illustrates the correlation between the original volume ratio of EG/H2O and the phase and morphology of the final product.
image file: c4ra07052f-s1.tif
Scheme 1 The correlation between the original volume ratio of EG/H2O and the phase and morphology of the final product.

3.3 Optical properties

Fig. 4 depicts the PL spectra of CePO4 nanocrystals with neat hexagonal phase, mixed phase and pure monoclinic form, respectively. All excitation spectra locate in the range from 240–320 nm, and all emission one in the range of 310–410 nm, which are in good agreement with ref. 24a. Nevertheless, some minor differences can still be found in PL spectra. In the excitation spectrum of hexagonal CePO4 (see Fig. 4a), for instance, a strong peak at 291 nm and two weak shoulder peaks at 287 and 304 nm can be seen. They correspond to the transitions from the ground state of 2F5/2 of Ce3+ to the different components of the excited Ce3+ 5d states split by the crystal field.24 Two excitation peaks with the equal intensity appear at 295 and 303 nm in the mixed CePO4 phase. However, the peak at 295 nm markedly increases in the excitation spectrum of neat monoclinic CePO4. Namely, the phase change from hexagonal to monoclinic causes slight change of their excitation spectra. Similar phenomenon is also found in their emission spectra. As shown in Fig. 4b, two strong peaks centered at 330 and 342 nm can be readily found in three spectra under the excitation of 290 nm light. They should come from the two transitions of Ce3+ ion emission: from the lowest component of the 2D state to the spin–orbit components of the ground state, 2F7/2 and 2F5/2.25 Different from the emission spectrum of hexagonal CePO4, however, two weak peaks at 365 and 380 nm can be detected in those of CePO4 with mixed phase and monoclinic form.
image file: c4ra07052f-f4.tif
Fig. 4 The excitation (a) and emission (b) spectra of the products prepared from the systems with the EG/H2O volume ratios of 0/19 (labeled as hexagonal), 14/5 (labeled as mixed phase) and 18/1 (labeled as monoclinic) at 110 °C for 30 min.

Moreover, many studies have shown that CePO4 can strongly absorb the ultraviolet light.21,25,26 Fig. 5 exhibits the UV-vis diffuse reflectance spectra of CePO4 nanocrystals with neat hexagonal phase, mixed phase and pure monoclinic form, respectively. Four absorption peaks at 217, 237, 258, and 274 nm are visible in each curve, which correspond to the transitions from the ground state 2F5/2 (4f1) of Ce3+ to the crystal field split levels of the Ce3+ 2D (5d1) excited states.21 Furthermore, the strongest peak locates at 274 nm, which is in good agreement with the previous report.21


image file: c4ra07052f-f5.tif
Fig. 5 UV/Vis absorption spectra of the products prepared from the systems with the EG/H2O volume ratios of 0/19 (labeled as hexagonal), 14/5 (labeled as mixed phase) and 18/1 (labeled as monoclinic) at 110 °C for 30 min.

4. Conclusions

In summary, the phase-controlled synthesis of CePO4 nanocrystals was successfully realized by a simple oil-bath route at 110 °C for 30 min, only through changing the original EG/H2O volume ratio. Experiments showed that the mixed phase of hexagonal and monoclinic CePO4 nanocrystals was produced at the EG/H2O volume ratio of 14/5. Hexagonal CePO4 was prepared at the EG/H2O volume ratio below 14/5; and monoclinic CePO4 was obtained at the volume ratio above 14/5. At the same time, with the increase of the EG/H2O volume ratio the morphology of the final product gradually evolved from long nanorods, to short nanorods, to nanorod bundles, to shuttle-like nanocrystals, and finally to spheroid nanocrystals. Furthermore, experiments showed that all products owned similar PL and UV-vis absorption spectra, but some minor differences could still be found owing to the phase and morphology change of the final product. The present synthesis route is simple and rapid for the phase- and shape-control of CePO4 nanocrystals, which paves a new path for the phase- and shape-controlled synthesis of other rare earth orthophosphates.

Acknowledgements

The authors thank the National Natural Science Foundation of China (21171005), Key Foundation of Chinese Ministry of Education (210098) and Special and Excellent Research Fund of Anhui Normal University for the fund support.

References

  1. (a) M. H. Lee, S. G. Oh, S. C. Yi, D. S. Seo, J. P. Hong, C. Kim, Y. K. Yoo and J. S. Yoo, J. Electrochem. Soc., 2000, 147, 3139 CrossRef CAS; (b) Q. H. Wang, A. A. Setlur, J. M. Lauerhaas, J. Y. Dai, W. Seelig and R. P. H. Chang, Appl. Phys. Lett., 1998, 72, 2912 CrossRef CAS.
  2. (a) B. Sun and H. Sirringhaus, Nano Lett., 2005, 5, 2408 CrossRef CAS PubMed; (b) D. V. Talapin and C. B. Murray, Science, 2005, 310, 86 CrossRef CAS PubMed.
  3. Y. Huang and C. M. Lieber, Pure Appl. Chem., 2004, 76, 2051 CrossRef CAS.
  4. L. Wang, C. Y. Yang and W. H. Tan, Nano Lett., 2005, 5, 37 CrossRef CAS PubMed.
  5. (a) M. Law, L. E. Greene, J. C. Johnson, R. Saykally and P. D. Yang, Nat. Mater., 2005, 4, 455 CrossRef CAS PubMed; (b) A. Shalav, B. S. Richards, T. Trupke, K. W. Kramer and H. U. Gudel, Appl. Phys. Lett., 2005, 86, 13505 CrossRef.
  6. (a) H. J. Choi, J. C. Johnson, R. R. He, S. K. Lee, F. Kim, P. Pauzauskie, J. Goldberger, R. J. Saykally and P. D. Yang, J. Phys. Chem. B, 2003, 107, 8721 CrossRef CAS; (b) J. C. Johnson, H. J. Choi, K. P. Knutsen, R. D. Schaller, P. D. Yang and R. J. Saykally, Nat. Mater., 2002, 1, 106 CrossRef CAS PubMed.
  7. K. Riwotzki, H. Meyssamy, A. Koronwski and M. Haase, J. Phys. Chem. B, 2000, 104, 2824 CrossRef CAS.
  8. (a) S. Lucas, E. Champion, D. Bregiroux, D. Bernache-Assollant and F. Audubert, J. Solid State Chem., 2004, 177, 1302 CrossRef CAS; (b) L. Karpowich, S. Wilcke, R. Yu, G. Harley, J. A. Reimer and L. C. De Jonghe, J. Solid State Chem., 2007, 180, 840 CrossRef CAS.
  9. Y. F. Lian and H. X. Dang, Tribology, 1993, 13, 183 CAS.
  10. (a) Y. Hikichi, T. Nomura, Y. Tanimura and S. Suzuki, J. Am. Ceram. Soc., 1990, 73, 3594 CrossRef CAS; (b) B. Li, L. Y. Shen, X. Z. Liu and T. M. Wang, J. Mater. Sci. Lett., 2000, 19, 343 CrossRef CAS.
  11. G. Richard, J. Herman and D. Manuel, Mater. Res. Bull., 1984, 19, 905 CrossRef.
  12. N. Kitamura, K. Amezawa, Y. Tomii, T. Hanada, N. Yamamoto, T. Omata and Y. Otsuka-Yao-Matsuo, J. Electrochem. Soc., 2004, 152, A658 CrossRef.
  13. W. Di, N. Shirahata, H. Zeng and Y. Sakka, Nanotechnology, 2010, 21, 365501 CrossRef PubMed.
  14. L. Wang, C. L. Zhou, H. Q. Chen, J. G. Chen, J. Fu and B. Ling, Analyst, 2010, 135, 2139 RSC.
  15. (a) F. Meiser, C. Cortez and F. Caruso, Angew. Chem., Int. Ed., 2004, 43, 5954 CrossRef CAS; (b) J. Q. Gu, J. Shen, L. D. Sun and C. H. Yan, J. Phys. Chem. C, 2008, 112, 6589 CrossRef CAS.
  16. W. Di, X. Wang and X. Ren, Nanotechnology, 2010, 21, 075709 CrossRef PubMed.
  17. Y. Xing, M. Li, S. A. Davis and S. Mann, J. Phys. Chem. B, 2006, 110, 1111 CrossRef CAS PubMed.
  18. Q. Li and V. W. Yam, Angew. Chem., Int. Ed., 2007, 46, 3486 CrossRef CAS PubMed.
  19. W. B. Bu, Z. L. Hua, H. R. Chen and J. L. Shi, J. Phys. Chem. B, 2005, 109, 14461 CrossRef CAS PubMed.
  20. M. H. Cao, C. W. Hu, Q. Y. Wu, C. X. Guo, Y. J. Qi and E. B. Wang, Nanotechnology, 2005, 16, 282 CrossRef CAS PubMed.
  21. Y. P. Fang, A. W. Xu, R. Q. Song, H. X. Zhang, L. P. You, J. C. Yu and H. Q. Liu, J. Am. Chem. Soc., 2003, 125, 16025 CrossRef CAS PubMed.
  22. Y. J. Zhang and H. M. Guan, J. Cryst. Growth, 2003, 256, 156 CrossRef CAS.
  23. G. Fasol, Science, 1998, 280, 545 CrossRef CAS.
  24. (a) M. Yang, H. P. You, Y. H. Zheng, K. Liu, Y. H. Song, Y. J. Huang, L. H. Zhang and H. J. Zhang, Inorg. Chem., 2009, 48, 11559 CrossRef CAS PubMed; (b) C. Zhang, J. Chen, X. F. Zhu, Y. C. Zhou and D. Q. Li, Chem. Mater., 2009, 21, 3570 CrossRef CAS.
  25. K. Riwotzki, H. Meyssamy, H. Schnablegger, A. Kornowski and M. Haase, Angew. Chem., Int. Ed., 2001, 40, 573 CrossRef CAS.
  26. (a) N. Imanaka, T. Masui and M. Itaya, Chem. Lett., 2003, 32, 400 CrossRef CAS; (b) N. Imanaka, T. Masui, H. Hirai and G. Y. Adachi, Chem. Mater., 2003, 15, 2289 CrossRef CAS.

This journal is © The Royal Society of Chemistry 2014
Click here to see how this site uses Cookies. View our privacy policy here.